193 related articles for article (PubMed ID: 31728905)
1. Common tools for pituitary adenomas research: cell lines and primary cells.
Zhu Z; Cui W; Zhu D; Gao N; Zhu Y
Pituitary; 2020 Apr; 23(2):182-188. PubMed ID: 31728905
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-estrogens on cell invasion and survival in pituitary adenoma cells: A systematic study.
Hannen R; Steffani M; Voellger B; Carl B; Wang J; Bartsch JW; Nimsky C
J Steroid Biochem Mol Biol; 2019 Mar; 187():88-96. PubMed ID: 30439415
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of dually targeting gene therapy system for pituitary adenomas].
Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of sonic hedgehog pathway components in pituitary adenomas: evidence for a direct role in hormone secretion and cell proliferation.
Vila G; Theodoropoulou M; Stalla J; Tonn JC; Losa M; Renner U; Stalla GK; Paez-Pereda M
J Clin Endocrinol Metab; 2005 Dec; 90(12):6687-94. PubMed ID: 16159933
[TBL] [Abstract][Full Text] [Related]
5. Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro.
Spangelo BL; Farrimond DD; Thapa M; Bulathsinghala CM; Bowman KL; Sareh A; Hughes FM; Goldstein AL; Badamchian M
Endocrinology; 1998 Apr; 139(4):2155-62. PubMed ID: 9529005
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line.
Oka H; Jin L; Kulig E; Scheithauer BW; Lloyd RV
Am J Pathol; 1999 Dec; 155(6):1893-900. PubMed ID: 10595920
[TBL] [Abstract][Full Text] [Related]
7. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: potential therapeutic application.
Hamilton HB; Hinton DR; Law RE; Gopalakrishna R; Su YZ; Chen ZH; Weiss MH; Couldwell WT
J Neurosurg; 1996 Aug; 85(2):329-34. PubMed ID: 8755764
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.
Lohrer P; Gloddek J; Hopfner U; Losa M; Uhl E; Pagotto U; Stalla GK; Renner U
Neuroendocrinology; 2001 Aug; 74(2):95-105. PubMed ID: 11474217
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.
Voellger B; Waldt N; Rupa R; Kirches E; Melhem O; Ochel HJ; Mawrin C; Firsching R
J Neurooncol; 2018 Sep; 139(3):573-582. PubMed ID: 29872948
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells.
Aiello A; Cassarino MF; Nanni S; Sesta A; Ferraú F; Grassi C; Losa M; Trimarchi F; Pontecorvi A; Cannavò S; Pecori Giraldi F; Farsetti A
Endocrine; 2018 Jan; 59(1):102-108. PubMed ID: 28447256
[TBL] [Abstract][Full Text] [Related]
12. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
[TBL] [Abstract][Full Text] [Related]
13. Effect of Gonadotropin and Adrenocorticotropic Hormone Secretion on Invasiveness of Clinically Nonfunctioning Pituitary Adenomas: A Cell Culture Study.
Usui S; Hama S; Tominaga A; Kinoshita Y; Kurisu K
World Neurosurg; 2016 Dec; 96():578-584.e1. PubMed ID: 27601155
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
Guo D; Han L; Shu K; Chen J; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells.
Xie R; He WQ; Shen M; Shou XF; Wang YF; Bao WM; Zhao Y
J Neurooncol; 2015 Oct; 125(1):79-89. PubMed ID: 26297046
[TBL] [Abstract][Full Text] [Related]
16. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
[TBL] [Abstract][Full Text] [Related]
17. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
[TBL] [Abstract][Full Text] [Related]
18. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
Deng J; Shi Y; Yin J
Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
[TBL] [Abstract][Full Text] [Related]
19. Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT-20 and TtT/GF by affecting expression of MMP-14 and ADAM12.
Zhang Z; Bartsch JW; Benzel J; Lei T; Nimsky C; Voellger B
FEBS Open Bio; 2020 Nov; 10(11):2489-2498. PubMed ID: 33030286
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
Mertens F; Gremeaux L; Chen J; Fu Q; Willems C; Roose H; Govaere O; Roskams T; Cristina C; Becú-Villalobos D; Jorissen M; Poorten VV; Bex M; van Loon J; Vankelecom H
Endocr Relat Cancer; 2015 Aug; 22(4):481-504. PubMed ID: 25921430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
